Substrate recognition domains within extracellular signal-regulated kinase mediate binding and catalytic activation of mitogen-activated protein kinase phosphatase-3
被引:81
作者:
Nichols, A
论文数: 0引用数: 0
h-index: 0
机构:Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Nichols, A
Camps, M
论文数: 0引用数: 0
h-index: 0
机构:Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Camps, M
Gillieron, C
论文数: 0引用数: 0
h-index: 0
机构:Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Gillieron, C
Chabert, C
论文数: 0引用数: 0
h-index: 0
机构:Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Chabert, C
Brunet, A
论文数: 0引用数: 0
h-index: 0
机构:Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Brunet, A
Wilsbacher, J
论文数: 0引用数: 0
h-index: 0
机构:Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Wilsbacher, J
Cobb, M
论文数: 0引用数: 0
h-index: 0
机构:Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Cobb, M
Pouyssegur, J
论文数: 0引用数: 0
h-index: 0
机构:Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Pouyssegur, J
Shaw, JP
论文数: 0引用数: 0
h-index: 0
机构:Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Shaw, JP
Arkinstall, S
论文数: 0引用数: 0
h-index: 0
机构:Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Arkinstall, S
机构:
[1] Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
[2] Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA
[3] Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75235 USA
[4] Univ Nice, Ctr Biochim, CNRS UMR 6543, F-06108 Nice, France
Mitogen-activated protein (MAP) kinase phosphatase-3 (MKP-3) is a dual specificity phosphatase that inactivates extracellular signal-regulated kinase (ERK) MAP kinases. This reflects tight and specific binding between ERR and the MKP-8 amino terminus with consequent phosphatase activation and dephosphorylation of the bound MAP kinase. We have used a series of p38/ERK chimeric molecules to identify domains within ERR necessary for binding and catalytic activation of MKP-3. These studies demonstrate that ERK kinase subdomains V-XI are necessary and sufficient for binding and catalytic activation of MKP-3. These domains constitute the major COOH-terminal structural lobe of ERK, p38/ERK chimeras possessing these regions display increased sensitivity to inactivation by MKP-3. These data also reveal an overlap between ERR domains interacting with MKP-3 and those known to confer substrate specificity on the ERK RAP kinase. Consistent with this, we show that peptides representing docking sites within the target substrates Elk-1 and p90(rsk) inhibit ERR-dependent activation of MKP-3. In addition, abolition of ERR-dependent phosphatase activation following mutation of a putative (k) under bar inase (i) under bar nteraction (m) under bar otif (KIM) within the MKP-3 NH2 terminus suggests that key sites of contact for the ERK COOH-terminal structural lobe include residues localized between the Cdc25 homology domains (CH2) found conserved between members of the DSP gene family.
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Camps, M
Nichols, A
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Nichols, A
Gillieron, C
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Gillieron, C
Antonsson, B
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Antonsson, B
Muda, M
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Muda, M
Chabert, C
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Chabert, C
Boschert, U
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Boschert, U
Arkinstall, S
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Camps, M
Nichols, A
论文数: 0引用数: 0
h-index: 0
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Nichols, A
Arkinstall, S
论文数: 0引用数: 0
h-index: 0
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Camps, M
Nichols, A
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Nichols, A
Gillieron, C
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Gillieron, C
Antonsson, B
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Antonsson, B
Muda, M
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Muda, M
Chabert, C
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Chabert, C
Boschert, U
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
Boschert, U
Arkinstall, S
论文数: 0引用数: 0
h-index: 0
机构:
Glaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, SwitzerlandGlaxo Wellcome Res & Dev SA, Geneva Biomed Res Inst, CH-1228 Geneva, Switzerland
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Camps, M
Nichols, A
论文数: 0引用数: 0
h-index: 0
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Nichols, A
Arkinstall, S
论文数: 0引用数: 0
h-index: 0
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland